Category: 23andMe Research

Studies Identify Five More Genetic Variants Associated with Alzheimer’s

Results published this week in the journal Nature Genetics identified five more genes associated with risk of developing Alzheimer’s, doubling the total number of genes known to be linked to the devastating disease. The two studies — one led by Paul Hollingworth and Julie Williams in Europe and the other by ...

Read more

Scientists Score a Breakthrough with Parkinson’s in a Petri Dish

Parkinson's disease (PD) is a relatively rare but devastating condition affecting 1-2% of Americans. Although some risk factors are known -- including genetic variants that predispose to the condition -- its exact causes and mechanisms remain a mystery, and development of treatments has been slow. 23andMe ...

Read more

An Update On Our Parkinson’s Research Community

At 23andMe, we are committed to advancing understanding of human health and disease, and to giving everyone an opportunity to participate in scientific research that is meaningful for them. We launched our first research community focused on Parkinson's disease in 2009 with those goals in mind. Less than two ...

Read more

A Sarcoma Community Update and Survivor Story

There is strength in numbers. With the help of our participants, we are well on our way to achieving our 1,000 person Sarcoma Community milestone. Thank you! We have over 500 individuals who have joined our sarcoma group from all over the world and with ties to several different patient organizations. Just ...

Read more

SNPwatch: Association Between FTO Variant and Obesity Depends on Age and Impacts Development

Editor’s note: Pending an FDA decision, 23andMe no longer offers new customers access to health reports referred to in this post. Customers who purchased prior to November 22, 2013 will still be able to see their health reports, but those who purchased after that time will not. Those customers will have ...

Read more

SNPwatch: Researchers Identify Variant Associated with Breast Density

Editor’s note: Pending an FDA decision, 23andMe no longer offers new customers access to health reports referred to in this post. Customers who purchased prior to November 22, 2013 will still be able to see their health reports, but those who purchased after that time will not. Those customers will have ...

Read more

SNPwatch: Researchers Identify Risk Variants Shared by Crohn’s Disease and Celiac Disease

Editor’s note: Pending an FDA decision, 23andMe no longer offers new customers access to health reports referred to in this post. Customers who purchased prior to November 22, 2013 will still be able to see their health reports, but those who purchased after that time will not. Those customers will have ...

Read more

Our Top Ten for 2010

2010 was a big year in more ways than one! Research uncovered more genetic variants associated with common diseases, fascinating portraits of our early ancestors, and new insights into the genetic diversity of modern populations. And on top of all that, 23andMe published its first research discoveries, ...

Read more

23andMe Launches Its First NIH Funded Study

  By Amy Kiefer and Kim Barnholt 23andMe is excited to announce the launch of our first National Institutes of Health (NIH) funded research project. In the fall of 2010, 23andMe received a NIH Small Business Innovative Research Grant (SBIR) to validate our web-based approach to pharmacogenomics ...

Read more

23andWe Research Update: Something Old and Something New

One of 23andMe’s core missions is to accelerate the pace of scientific research and contribute to our understanding of the genetic basis of human health and traits. Central to this mission is our growing database of genotyped customers who have consented to allow us to incorporate their genetic data and ...

Read more

Return to top